Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Short Interest Up 60.2% in February

Posted by Scott Moore on Mar 4th, 2025

Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) was the recipient of a significant increase in short interest in February. As of February 15th, there was short interest totalling 756,800 shares, an increase of 60.2% from the January 31st total of 472,300 shares. Currently, 12.2% of the shares of the stock are sold short. Based on an average daily volume of 809,000 shares, the days-to-cover ratio is presently 0.9 days.

Bullfrog AI Stock Performance

Bullfrog AI stock remained flat at $1.89 during mid-day trading on Tuesday. 171,834 shares of the company were exchanged, compared to its average volume of 324,254. The firm’s 50-day moving average price is $2.51 and its 200 day moving average price is $2.46. Bullfrog AI has a 52 week low of $1.43 and a 52 week high of $4.84. The stock has a market capitalization of $16.47 million, a P/E ratio of -2.22 and a beta of 0.18.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in BFRG. Geode Capital Management LLC boosted its holdings in shares of Bullfrog AI by 31.0% in the 4th quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock worth $94,000 after purchasing an additional 11,140 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Bullfrog AI in the fourth quarter valued at $30,000. Finally, Two Sigma Securities LLC bought a new stake in shares of Bullfrog AI in the 4th quarter worth about $41,000. Hedge funds and other institutional investors own 0.96% of the company’s stock.

Bullfrog AI Company Profile

(Get Free Report)

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.